The Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.
North Korea on May 21 reported more than 200,000 new patients suffering from fever for a fifth consecutive day, as the country fought its first confirmed coronavirus outbreak.
Where we are: Omicron BA.2 persists while vaccines lower risk of long COVID
B.1.1.7 "Kent" strain (United Kingdom), B.1.1.7 Variant (UK), Bebtelovimab (LY-CoV1404; LY3853113), BNT162b2 (Pfizer and BioNTech), C.1.2 Covid-19 Variant (South Africa), Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Antibodies, COVID-19 Deaths, COVID-19 Variant B.1.526 (New York), Covid-19 Variants, Etesevimab (Lilly), Evusheld (tixagevimab and cilgavimab; AstraZeneca), Hospitalizations, Hospitalized COVID-19 Patients, Molnupiravir, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), Omicron BA.2, Pandemics, TherapeuticsThere appears to be a rise in COVID-19 illnesses, driven by Omicron subvariants, which may be better able to evade immunity from vaccines and previous infections and lower public health measures by the public such as masking and social distancing.
Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen
Antivirals, Clinical Trials, COVID-19 cases, COVID-19 Studies, COVID-19 Therapeutics, Dr. Anthony Fauci (Director), Emergency Use Authorization (EUA), National Institutes of Health, Omicron (B.1.1.529) (South Africa), Paxlovid, Pfizer, R&D, TherapeuticsWith increasing concerns about COVID-19 reinfection, Pfizer and the National Institutes of Health are discussing potential studies regarding a longer treatment period with the antiviral medication Paxlovid.
Study: mRNA vaccines perform better against COVID-19 variants of concern
AstraZeneca, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease (COVID-19) Pandemic, COVID-19 Studies, COVID-19 Vaccines, Covid-19 Variants, Janssen, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Messenger RNA (mRNA) Vaccines, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemics, Peer-Reviewed Analysis, Pfizer, PLOS Medicine, R&D, SARS-CoV-2 virus, Therapeutics, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)In a peer-reviewed study published May 17 in PLOS Medicine, scientists found that mRNA-based COVID-19 vaccines were superior to adenovirus vector-based ones across major variants of the SARS-CoV-2 virus.
As U.S. COVID-19 cases rise, so does demand for antivirals
Antivirals, Apple, BNT162b2 (Pfizer and BioNTech), CDC, Connecticut, COVID-19 booster shots, COVID-19 cases, COVID-19 Therapeutics, COVID-19 Vaccines, Delaware, Department of Health and Human Services (HHS), Emergency Use Authorization (EUA), FDA, Health Officials, Hospitalized COVID-19 Patients, Maine, Massachusetts, Merck, Molnupiravir, New York, Northeast, Omicron (B.1.1.529) (South Africa), Omicron BA.2, Paxlovid, Pfizer, Regions, Reuters Tally, Rhode Island, Therapeutics, U.S. government, United States, White HouseRising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc.’s oral antiviral treatment Paxlovid seeing a 315 percent jump over the past four weeks, U.S. health officials said on May 17.
Shanghai targets June COVID lockdown exit as China economy slumps
China, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Restrictions, Coronavirus surge, COVID guidelines, Covid-19 Airborne Transmission, COVID-19 booster shots, COVID-19 cases, Covid-19 fatality rate, COVID-19 Lockdown Measures, COVID-19 Prevention Measures, COVID-19 protocols, Covid-19 Quarantine, COVID-19 recommendations, COVID-19 risk, COVID-19 shots, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 transmission, COVID-19 vaccination rates, Covid-19 Variants, Mask-wearing, Pandemics, Shanghai, TherapeuticsShanghai set out plans on May 16 for the end of a painful COVID-19 lockdown that has lasted more than six weeks, heavily bruising China’s economy, and for the return of more normal life from June 1.
Half of the COVID-19 patients discharged from a Chinese hospital in early 2020 still have at least one symptom two years later, a new study shows. Additionally, new findings suggest patterns of inflammatory proteins in the blood of people with long COVID may someday help guide individualized treatment.
Biden marks 1 million Americans dead from COVID
Congress, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Coronavirus Mutations, Coronavirus Restrictions, Coronavirus surge, COVID-19 booster shots, COVID-19 Deaths, COVID-19 Infections, COVID-19 shots, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 treatment pill, COVID-19 vaccination rates, Covid-19 Variants, Joe Biden, Pandemics, Reuters Tally, SARS-CoV-2 virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Summits, United States, White House, White House coronavirus task forcePresident Joe Biden on May 12 commemorated the death of 1 million people in the United States from COVID-19, marking what he called “a tragic milestone” and urging Americans to “remain vigilant” amid the ongoing pandemic.
North Korea reports first COVID outbreak, orders lockdown in “gravest emergency”
Coronavirus, COVAX Facility, COVID-19 Infections, COVID-19 Lockdown Measures, COVID-19 vaccination rates, COVID-19 Vaccinations, North Korea, Omicron (B.1.1.529) (South Africa), Outbreaks, Pyongyang, South Korea, World Health OrganizationNorth Korea reported the country’s first COVID-19 outbreak on May 12, calling it the “gravest national emergency” and ordering a national lockdown, with state media saying an Omicron variant had been detected in the capital, Pyongyang.